-+ 0.00%
-+ 0.00%
-+ 0.00%

Astellas revised its net profit forecast upwards by 20% for this fiscal year, driven by growth in major products such as anticancer drugs.

NIKKEI QUICK·11/04/2026 06:53:06

Please log in to view news